These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9818542)

  • 1. Scleroderma: immunopathogenesis and treatment.
    Rose NR; Leskovsek N
    Immunol Today; 1998 Nov; 19(11):499-501. PubMed ID: 9818542
    [No Abstract]   [Full Text] [Related]  

  • 2. The autoinflammatory side of systemic sclerosis.
    De Santis M; Selmi C
    Isr Med Assoc J; 2015 Jan; 17(1):47-9. PubMed ID: 25739177
    [No Abstract]   [Full Text] [Related]  

  • 3. Fighting the fires of systemic sclerosis.
    Lancet; 2010 Feb; 375(9714):526. PubMed ID: 20159272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pregnancy in systemic autoimmune diseases].
    Held E
    Internist (Berl); 1992 Feb; 33(2):90-9. PubMed ID: 1568833
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
    Cohen Y; Nagler A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymphocyte transformation in autoimmune skin diseases].
    Mészáros C; Nagy E
    Z Haut Geschlechtskr; 1969 Apr; 44(8):265-8. PubMed ID: 4188257
    [No Abstract]   [Full Text] [Related]  

  • 7. Scleroderma.
    Gilliam AC
    Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
    Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
    Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell therapy in autoimmune diseases].
    Farge-Bancel D
    Rev Med Interne; 2011 Dec; 32 Suppl 2():S204-7. PubMed ID: 22056080
    [No Abstract]   [Full Text] [Related]  

  • 10. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].
    van den Hoogen FH; Schattenberg AV; Breedveld FC; Fibbe WE; van de Putte LB
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2061-5. PubMed ID: 9550764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood lymphocyte transformation test in various skin diseases of allergic origin].
    Panasiuk J
    Przegl Dermatol; 1980; 67(6):823-9. PubMed ID: 6972552
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immobilized antigenic preparations with magnetic properties in the diagnosis and treatment of rheumatic diseases].
    Zborovskiĭ AB; Gontar' IP
    Vestn Ross Akad Med Nauk; 1999; (5):45-9. PubMed ID: 10394301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell therapies for systemic sclerosis.
    Cipriani P; Ruscitti P; Giacomelli R
    Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and progress in immunotherapies for organ involvements in systemic autoimmune diseases].
    Yasuda S; Kono M; Shimamura S; Kurita T; Odani T; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):8-17. PubMed ID: 27181229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoimmune theory of pathogenesis of systemic scleroderma].
    Nadashkevich ON
    Lik Sprava; 2001; (4):15-7. PubMed ID: 11692700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens and scleroderma.
    Ercilla MG; Arriaga F; Gratacós MR; Coll J; Lecha V; Vives J; Castillo R
    Arch Dermatol Res; 1981; 271(4):381-5. PubMed ID: 6949497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.